EP 4164653 A1 20230419 - MORPHIC FORMS OF TRILACICLIB AND METHODS OF MANUFACTURE THEREOF
Title (en)
MORPHIC FORMS OF TRILACICLIB AND METHODS OF MANUFACTURE THEREOF
Title (de)
MORPHISCHE FORMEN VON TRILACICLIB UND VERFAHREN ZUR HERSTELLUNG DAVON
Title (fr)
FORMES MORPHIQUES DE TRILACICLIB ET LEURS PROCÉDÉS DE FABRICATION
Publication
Application
Priority
- US 202063039372 P 20200615
- US 202017097854 A 20201113
- US 202163180578 P 20210427
- US 2021037462 W 20210615
Abstract (en)
[origin: WO2021257587A1] An advantageous isolated morphic form of trilaciclib which is 2'-((5-(4- methylpiperazin-1-yl)pyridin-2-yl)amino)-7',8'-dihydro-6'H-spiro[cyclohexane-1,9'- pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidin]-6'-one, for example in the form of a dihydrochloride salt or a dihydrochloride, dihydrate.
IPC 8 full level
A61K 31/519 (2006.01); C07D 487/20 (2006.01)
CPC (source: EP)
C07D 487/22 (2013.01)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2021257587 A1 20211223; CN 116157403 A 20230523; EP 4164653 A1 20230419; EP 4164653 A4 20240619; TW 202214650 A 20220416
DOCDB simple family (application)
US 2021037462 W 20210615; CN 202180055673 A 20210615; EP 21826036 A 20210615; TW 110121769 A 20210615